Faster diagnosis and quicker cancer care for people with Kaposi sarcoma in East Africa
Project 2: Rapid Case Ascertainment as a Tool for Epidemiologic Investigation and Efficient Linkage to Care in HIV-infected Patients Diagnosed with Kaposi Sarcoma in East Africa
This project rapidly finds adults newly diagnosed with Kaposi sarcoma in East Africa and helps them get linked to HIV and cancer care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11112403 on NIH RePORTER |
What this research studies
If I have HIV and Kaposi sarcoma, the team works to identify people like me very soon after diagnosis using clinic records and outreach called rapid case ascertainment. They collect early clinical information and arrange faster referrals so people can start HIV and cancer treatment sooner. The project tests simple support steps to help patients navigate the health system and tracks outcomes such as disease stage at diagnosis and survival. The work is based in Uganda and Kenya and builds on earlier efforts using this rapid approach for KS.
Who could benefit from this research
Good fit: Adults aged 21 and older living with HIV who are newly diagnosed with Kaposi sarcoma at participating clinics in Uganda or Kenya would be the ideal candidates.
Not a fit: People without Kaposi sarcoma, children under 21, or individuals outside the participating East African sites would not be eligible and would not directly benefit from this project.
Why it matters
Potential benefit: If successful, this could lead to earlier diagnosis, faster start of HIV and cancer treatment, and improved survival for people with Kaposi sarcoma in the region.
How similar studies have performed: The team previously piloted rapid case ascertainment for Kaposi sarcoma in Uganda and Kenya and showed it can identify patients quickly, but it remains unclear whether this approach improves long-term survival.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Byakwaga, Helen — University of California, San Francisco
- Study coordinator: Byakwaga, Helen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.